Novel Alzheimer disease treatments and reconsideration of US pharmaceutical reimbursement policy

17 July 2023 - While donanemab appears to be among the first therapies to demonstrate measurable clinical benefit for Alzheimer's disease, ...

Read more →

FDA's Gottlieb 'extremely worried' on CAR-T reimbursement

24 October 2018 - FDA Commissioner Scott Gottlieb stressed the need for reform on the reimbursement side of medicine, calling it ...

Read more →